Validation of the IMS CORE Diabetes Model
作者： Phil McEwan , Volker Foos , James L. Palmer , Mark Lamotte , Adam Lloyd
DOI: 10.1016/J.JVAL.2014.07.007
关键词:
摘要: … other validation studies published in the health economic literature, we present scatterplots of observed versus predicted end points along with the coefficient of determination (R 2 ). …
elsevier.com
sci-hub.se 参考文章(59)
J. Cederholm, K. Eeg-Olofsson, B. Eliasson, B. Zethelius, P. M. Nilsson, S. Gudbjornsdottir, , Risk Prediction of Cardiovascular Disease in Type 2 Diabetes A risk equation from the Swedish National Diabetes Register Diabetes Care. ,vol. 31, pp. 2038- 2043 ,(2008) , 10.2337/DC08-0662
Phil McEwan, John R. Peters, Klas Bergenheim, Craig J. Currie, Evaluation of the costs and outcomes from changes in risk factors in type 2 diabetes using the Cardiff stochastic simulation cost-utility model (DiabForecaster) Current Medical Research and Opinion. ,vol. 22, pp. 121- 129 ,(2006) , 10.1185/030079906X80350
William Duckworth, Carlos Abraira, Thomas Moritz, Domenic Reda, Nicholas Emanuele, Peter D. Reaven, Franklin J. Zieve, Jennifer Marks, Stephen N. Davis, Rodney Hayward, Stuart R. Warren, Steven Goldman, Madeline McCarren, Mary Ellen Vitek, William G. Henderson, Grant D. Huang, Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes The New England Journal of Medicine. ,vol. 360, pp. 129- 139 ,(2009) , 10.1056/NEJMOA0808431
Viti Kothari, Richard J. Stevens, Amanda I. Adler, Irene M. Stratton, Susan E. Manley, H. Andrew Neil, Rudy R. Holman, UKPDS 60: Risk of Stroke in Type 2 Diabetes Estimated by the UK Prospective Diabetes Study Risk Engine Stroke. ,vol. 33, pp. 1776- 1781 ,(2002) , 10.1161/01.STR.0000020091.07144.C7
Yevgeniy Samyshkin, Anne-Laure Guillermin, Jennie H. Best, Steven C. Brunell, Adam Lloyd, Long-term cost-utility analysis of exenatide once weekly versus insulin glargine for the treatment of type 2 diabetes patients in the US. Journal of Medical Economics. ,vol. 15, pp. 6- 13 ,(2012) , 10.3111/13696998.2012.708691
Andrew J. Palmer, Stéphane Roze, William J. Valentine, Michael E. Minshall, Volker Foos, Francesco M. Lurati, Morten Lammert, Giatgen A. Spinas, The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Cost- effectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making Current Medical Research and Opinion. ,vol. 20, ,(2004) , 10.1185/030079904X1980
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil, None, 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes The New England Journal of Medicine. ,vol. 359, pp. 1577- 1589 ,(2008) , 10.1056/NEJMOA0806470
John B. Watkins, Michael E. Minshall, Sean D. Sullivan, Application of Economic Analyses in U.S. Managed Care Formulary Decisions: A Private Payer's Experience Journal of Managed Care Pharmacy. ,vol. 12, pp. 726- 735 ,(2006) , 10.18553/JMCP.2006.12.9.726
R. K. Simmons, R. L. Coleman, H. C. Price, R. R. Holman, K.-T. Khaw, N. J. Wareham, S. J. Griffin, Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort Diabetes Care. ,vol. 32, pp. 708- 713 ,(2009) , 10.2337/DC08-1918
W J Valentine, A Bagust, J Brown, S Roze, P Clarke, M Holmes, P McEwan, R Coleman, A M Gray, A J Palmer, R Kahn, M Gillett, S Walzer, D M Eddy, R Stevens, E Müller, S Sorensen, 'Computer modeling of diabetes and its complications: A report on the Fourth Mount Hood Challenge Meeting' Diabetes Care. ,vol. 30, pp. 1638- 1646 ,(2007)